94 related articles for article (PubMed ID: 2535958)
1. Feline lymphomas: immunological and cytochemical characterization.
Rojko JL; Kociba GJ; Abkowitz JL; Hamilton KL; Hardy WD; Ihle JN; O'Brien SJ
Cancer Res; 1989 Jan; 49(2):345-51. PubMed ID: 2535958
[TBL] [Abstract][Full Text] [Related]
2. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
[TBL] [Abstract][Full Text] [Related]
3. Feline malignant lymphomas: comparison of morphologic and immunologic characteristics.
Holmberg CA; Manning JS; Osburn BI
Am J Vet Res; 1976 Dec; 37(12):1455-60. PubMed ID: 793460
[TBL] [Abstract][Full Text] [Related]
4. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
Jackson ML; Wood SL; Misra V; Haines DM
Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
[TBL] [Abstract][Full Text] [Related]
6. Thymic origin of the prolactin-dependent Nb2 lymphoma cell line.
Fleming WH; Pettigrew NM; Matusik RJ; Friesen HG
Cancer Res; 1982 Aug; 42(8):3138-41. PubMed ID: 7046917
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Lymphoma at Injection Sites: Pathological, Immunophenotypical, and Molecular Characterization in 17 Cats.
Roccabianca P; Avallone G; Rodriguez A; Crippa L; Lepri E; Giudice C; Caniatti M; Moore PF; Affolter VK
Vet Pathol; 2016 Jul; 53(4):823-32. PubMed ID: 26933095
[TBL] [Abstract][Full Text] [Related]
8. Feline skin lymphoma: characterization of tumor and identification of tumor-stimulating serum factor(s).
Legendre AM; Becker PU
Am J Vet Res; 1979 Dec; 40(12):1805-7. PubMed ID: 316659
[TBL] [Abstract][Full Text] [Related]
9. Guinea pig erythrocyte rosette formation as a nonspecific cell surface receptor assay in the cat.
Wellman ML; Kociba GJ; Rojko JL
Am J Vet Res; 1986 Feb; 47(2):433-7. PubMed ID: 3954230
[TBL] [Abstract][Full Text] [Related]
10. Comparison of feline leukemia virus-infected and normal cat T-cell lines in interleukin 2-conditioned medium.
Grant CK; Ernisse BJ; Pontefract R
Cancer Res; 1984 Feb; 44(2):498-502. PubMed ID: 6318972
[TBL] [Abstract][Full Text] [Related]
11. Two cases of FeLV-associated dermatoses.
Favrot C; Wilhelm S; Grest P; Meli ML; Hofmann-Lehmann R; Kipar A
Vet Dermatol; 2005 Dec; 16(6):407-12. PubMed ID: 16359309
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
Athas GB; Choi B; Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1995 Dec; 214(2):431-8. PubMed ID: 8553544
[TBL] [Abstract][Full Text] [Related]
13. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
Lizonová A; Grófová M
Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
[TBL] [Abstract][Full Text] [Related]
14. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
15. Feline large granular lymphocyte (LGL) lymphoma with secondary leukemia: primary intestinal origin with predominance of a CD3/CD8(alpha)(alpha) phenotype.
Roccabianca P; Vernau W; Caniatti M; Moore PF
Vet Pathol; 2006 Jan; 43(1):15-28. PubMed ID: 16407483
[TBL] [Abstract][Full Text] [Related]
16. In vitro selective suppression of feline myeloid colony formation is attributable to molecularly cloned strain of feline leukemia virus with unique long terminal repeat.
Nagashima N; Hisasue M; Nishigaki K; Miyazawa T; Kano R; Hasegawa A
Res Vet Sci; 2005 Apr; 78(2):151-4. PubMed ID: 15563922
[TBL] [Abstract][Full Text] [Related]
17. Immunologic profiles of cats with persistent, naturally acquired feline leukemia virus infection.
Reimann KA; Bull RW; Crow SE; Coffman P; Raskin RE
Am J Vet Res; 1986 Sep; 47(9):1935-9. PubMed ID: 3021028
[TBL] [Abstract][Full Text] [Related]
18. Feline upper respiratory tract lymphoma: site, cyto-histology, phenotype, FeLV expression, and prognosis.
Santagostino SF; Mortellaro CM; Boracchi P; Avallone G; Caniatti M; Forlani A; Roccabianca P
Vet Pathol; 2015 Mar; 52(2):250-9. PubMed ID: 24903757
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma.
Fujino Y; Liao CP; Zhao YS; Pan J; Mathes LE; Hayes KA; Ohno K; Tsujimoto H; Roy-Burman P
Virology; 2009 Mar; 386(1):16-22. PubMed ID: 19203775
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS.
Mullins JI; Chen CS; Hoover EA
Nature; 1986 Jan 23-29; 319(6051):333-6. PubMed ID: 3001539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
